Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download case study

How site enablement and activation became the strongest recruitment channel for a complex genetic trial

How site enablement nearly doubled randomizations in a genetically targeted Parkinson’s trial

Sano partnered with a neuro-focused biotech company to support recruitment for a Phase 2 Parkinson’s disease trial targeting a genetically defined patient population.

Rather than treating sites as a downstream referral channel, Sano designed and executed a site-enabled recruitment and genetic testing strategy that integrated site workflows, patient experience, and trial operations.

The outcome was a meaningful shift in where qualified patients came from and how effectively the study could randomize eligible participants.

The case study outlines how Sano:
✅ Designed a site-first recruitment strategy for a genetically stratified Parkinson’s trial
✅ Enabled sites to identify, educate, and refer patients with minimal operational burden
✅ Integrated genetic testing and patient support into site workflows
✅ Achieved 44% of randomizations through site referrals
✅ Used early recruitment signals to support testing expansion and reduce enrollment risk

Download now to learn more.

Sitegroup-1